The Vascular Boot Market is estimated to secure a valuation of USD 1.1 billion in 2023 and is estimated to rise to USD 1.5 billion by 2033. The market is anticipated at a CAGR of 3.2% during the forecast period. The factors accelerating the demand for vascular boots are as follows:
| Data Points | Key Statistics |
|---|---|
| Expected Market Value in 2023 | USD 1.1 billion |
| Projected Market Value in 2033 | USD 1.5 billion |
| Growth Rate (2023 to 2033) | CAGR of 3.2% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Principal Consultant
The leading players operating in the vascular boot market are Medtronic, Becton, Boston scientific corporation, Biosensor International Group, Abbott, iVascular, Cardinal Health, Dickinson & Company, B. Braun Melsungen, Terumo Corporation, BIOTRONIC SE & Co.KG among others.
The vascular boot market is highly fragmented with the presence of many large and small-scale players. The major players in the vascular boot market are focusing on strategies like mergers, partnerships acquisitions, and increasing their brand presence. Also, the leading players are focusing on innovation to develop innovative products. Following are some of the developments in the market.
The vascular boot market is expected to grow in the coming years. The increasing demand for vascular boots for patients with arterial thrombolytics is expected to drive market growth during the forecast period. Also, the availability of vascular boots in hospital pharmacies, retail pharmacies, and online stores increases the sales of the market. Several start-ups have entered the vascular boot market with innovative products and technology.
According to the latest research by FMI, Vascular boot market is set to witness a 5.5% growth during the year 2023 to 2033. The market is expected to witness growth owing to an increase in demand for vascular boots which offer complete and accurate offloading of the heels along with it naturally warms up the limb.
Vascular boots are used by various interventionalists and surgeons.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Primary factor driving the growth of the vascular boot market is its various benefits which provide quick and easy support to the users. Total offloading is offered along with complete floating of the heel and layers. No pressure points are present in the vascular boots. Furthermore, it is properly insulated to improve the warmth level of the limb. Vascular boot devices consist of foot drop prevention wings which are removable in nature.
Moreover, vascular boot devices do not consist of natural rubber latex due to which it provides enhanced comfort level to the patients.
Vascular boot is basically used on patients on arterial thrombolytics, undergoing intra-aortic pump procedures (IABP) along with post -BKA contralateral foot. Vascular boot is majorly used to prevent heel ulcers also foot drop.
Furthermore, it is also used for patients suffering from cold mottled feet, diabetic neuropathy, pressure related injuries, spinal cord injury, peripheral vascular disease and many more. Therefore, such advantageous benefit provided by vascular boot devices augment the market growth over the forecast period.
Rising prevalence and awareness about various injuries such as cold mottled feet, diabetic neuropathy, pressure related injuries, spinal cord injury, peripheral vascular disease and many more, together with increasing healthcare expenditure is boosting the market growth.
Moreover, extensive R&D activities and effort by key players to develop cost-effective and advanced vascular boots are acting as major growth drivers in the USA market. Similarly, manufacturers are coming up with point-of-care devices due to a shifting trend towards patient-self-testing, which is further expected to supplement the growth of the market during the forecast period.
Moreover, technological advancements in case of vascular boot devices are likely to augment the market growth.
Europe would witness the highest growth after North America due to the rising prevalence of the vascular related injuries in the region. According to the World Health Organization, in the European region, numerous types of heels related issues affect more than 50 million children and adults.
Cold molted feet is one of the most commonly reported diseases which is mainly affecting young people, contribute strongly to vascular injuries and lost productivity in Europe and result into increased the healthcare burden in Europe. Thus the government is taking the initiative to create awareness among the people to use vascular devices to reduce the healthcare burden.
Increasing government initiative and increasing incidences of vascular related issues in the region is expected to drive Vascular boot market in Europe.
Some of the leading manufacturers and suppliers of Vascular boot market Testing include Medtronic (Ireland), Becton, Boston Scientific Corporation (USA), Biosensors International Group (Singapore), Abbott (USA), iVascular (Spain), Cardinal Health (USA), Dickinson and Company (USA), B. Braun Melsungen (Germany), Terumo Corporation (Japan), and BIOTRONIK SE & Co. KG (Germany)
The Vascular boot market is fragmented with the availability of different global and regional manufacturers. Increasing focus on research and development to launch safe and effective vascular boot treatment owing to the growing need for treatment of heel related issues would explore opportunities for the manufacturers in the vascular devices market. Acquisitions and mergers and expansion of product portfolios are the strategies adopted by these companies to increase market share.
The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain.
The report provides an in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
1. Executive Summary 2. Industry Introduction, including Taxonomy and Market Definition 3. Market Trends and Success Factors, including Macro-economic Factors, Market Dynamics, and Recent Industry Developments 4. Global Market Demand Analysis and Forecast, including Historical Analysis and Future Projections 5. Pricing Analysis 6. Global Market Analysis and Forecast 6.1. Product Type 6.2. Indication 6.3. Distribution Channel 7. Global Market Analysis and Forecast, By Product Type 7.1. Angioplasty Balloons 7.2. Angioplasty Stents 7.3. Catheters 7.4. EVAR Stent Grafts 7.5. Other Devices 7.6. Guidewires 7.7. Vascular Closure Devices 7.8. Introducer Sheaths 7.9. Balloon Inflation Devices 8. Global Market Analysis and Forecast, By Indication 8.1. Heels 8.2. Ulcers 8.3. Limb 9. Global Market Analysis and Forecast, By Distribution Channel 9.1. Hospital Pharmacies 9.2. Retail Pharmacies 9.3. Online Pharmacies 10. Global Market Analysis and Forecast, By Region 10.1. North America 10.2. Latin America 10.3. Europe 10.4. South Asia 10.5. East Asia 10.6. Oceania 10.7. Middle East & Africa 11. North America Sales Analysis and Forecast, by Key Segments and Countries 12. Latin America Sales Analysis and Forecast, by Key Segments and Countries 13. Europe Sales Analysis and Forecast, by Key Segments and Countries 14. South Asia Sales Analysis and Forecast, by Key Segments and Countries 15. East Asia Sales Analysis and Forecast, by Key Segments and Countries 16. Oceania Sales Analysis and Forecast, by Key Segments and Countries 17. Middle East & Africa Sales Analysis and Forecast, by Key Segments and Countries 18. Sales Forecast by Product Type, Indication, and Distribution Channel for 30 Countries 19. Competition Outlook, including Market Structure Analysis, Company Share Analysis by Key Players, and Competition Dashboard 20. Company Profile 20.1. Medtronic (Ireland) 20.2. Becton 20.3. Boston Scientific Corporation (US) 20.4. Biosensors International Group (Singapore) 20.5. Abbott (US) 20.6. iVascular (Spain) 20.7. Cardinal Health (US) 20.8. Dickinson and Company (US) 20.9. B. Braun Melsungen (Germany) 20.10. Terumo Corporation (Japan) 20.11. BIOTRONIK SE & Co. KG (Germany)
Explore Healthcare Insights
View Reports
Vascular Boot market
